
Shares of Tylenol maker Kenvue KVUE.N rise 2.13% to $23.24
Dan Loeb's Third Point has built a stake in the company, the Financial Times reports, citing people familiar with the matter
The size of Third Point's stake and the extent to which the hedge fund has engaged with Kenvue could not immediately be established, FT said
Kenvue did not immediately respond to a Reuters request for comment
In March, Kenvue appointed three new directors to its board as part of an agreement with activist investor Starboard Value
Up to last close, stock has risen 9.7% YTD